BPC-157/TB-500(Wolverine)

Overview

This research blend contains two synthetic peptides — BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 Fragment) — each provided at 10 mg per vial for a combined total of 20 mg. Both compounds are investigated solely in non-clinical laboratory environments for their roles in cellular signaling, tissue model repair mechanisms, and cytoprotective pathways. Research focuses on molecular interactions that support actin regulation, angiogenesis models, and cell migration behavior under controlled experimental conditions.

Specifications

• Total Unit Size: 20 mg per vial (10 mg BPC-157 + 10 mg TB-500)

• Form: Lyophilized powder

• Storage: Store dry at 2 °C–8 °C. After reconstitution, refrigerate at 2 °C–8 °C and use within 10–14 days.

• Documentation: Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) available upon request.

Research Context

In vitro and preclinical studies have examined this blend in relation to:

• Cellular migration and angiogenic signaling pathways under controlled assay conditions

• Actin-binding and cytoskeletal regulation mechanisms in tissue model systems

• Cell proliferation and stress-response signaling during laboratory assays

• Comparative evaluation of cytoprotective peptides in non-human research models

All references concern non-clinical investigation only and do not indicate any verified safety or efficacy in humans or animals.

Intended Use / Restrictions

• For laboratory research use only

• Not for human or veterinary use

• Not a drug, dietary supplement, or medical device

• Buyer must be a qualified researcher or institution and is responsible for all lawful handling and compliance with applicable regulations.

Important Notice

This material is provided strictly for scientific and educational research. No claims are made regarding its therapeutic, diagnostic, or preventive potential. The seller does not represent this product as safe or effective for use in humans or animals. Proper storage, handling, and disposal must follow institutional biosafety protocols.